News for Healthier Living

Liver-Directed Treatment Is Associated with Improved Survival and Increased Response to Immune Checkpoint Blockade in Metastatic Uveal Melanoma: Results From a Retrospective Multicenter Trial

Researchers from Friedrich-Alexander-University Erlangen-Nurnberg (FAU), et al. have published a paper, in which they analyzed 182 metastatic uveal melanoma patients treated with ICB. The study found cohort A had longer median OS, better PFS trend, and higher ICB response rates, suggesting LDT+ICB may benefit these patients.

September 3, 2025


September 3 2025

September 2 2025

September 1 2025

August 31 2025

August 30 2025

August 29 2025

August 28 2025

August 27 2025

August 26 2025

August 25 2025

August 24 2025

August 23 2025

August 22 2025

August 21 2025

August 20 2025